Cipdapla 5mg Tablet
Marketer
Cipla Ltd
Salt Composition
Dapagliflozin (5mg)
Overview Cipdapla 5mg Tablet
Dapciprin 5mg tablets are indicated, either independently or adjunctively, for managing type 2 diabetes mellitus. This medication effectively regulates elevated blood glucose, mitigating the likelihood of severe diabetic complications and contributing to cardiovascular health protection. Dapciprin 5mg may be ingested with or without food, consistently at the same time daily, as determined by your physician. Discontinuation requires medical consultation, as abrupt cessation can elevate blood sugar, raising the risk of serious consequences such as nephropathy and vision impairment. This drug forms one element of a comprehensive diabetes management plan incorporating a balanced diet, regular exercise, and weight management, all under medical guidance. Common adverse effects may include vaginal candidiasis, nasopharyngitis, and urinary tract infections. Significant diuresis is possible; increased fluid intake is crucial to avoid dehydration. Practicing good hygiene minimizes the risk of genital fungal infections. Prior to commencing treatment, patients with renal or hepatic impairment, urinary tract infections, or those using diuretics, should inform their doctor. Pregnant or lactating individuals should seek medical advice. Excessive alcohol consumption should be avoided due to the potential exacerbation of adverse reactions. Regular blood glucose monitoring is essential throughout treatment.
Primary Ingredients of Cipdapla 5mg Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Cipdapla 5mg Tablet
Managing type 2 diabetes
Major Benefits of Cipdapla 5mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Cipdapla 5mg Tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Cipdapla 5mg Tablet:
- Polyuria
- Nausea
- Vomiting
- Dyslipidemia
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
How to use Cipdapla 5mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Cipdapla 5mg Tablets can be consumed with or without food, although consistent timing is recommended.
How Cipdapla 5mg Tablet works:
Cipdapla 5mg tablets are used to manage diabetes. They function by facilitating the excretion of surplus glucose via urination.
SAFETY ADVICE
AlcoholUNSAFE
Combining Cipdapla 5mg Tablet with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Cipdapla 5mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Cipdapla 5mg tablets while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The use of Cipdapla 5mg Tablets is likely inadvisable for individuals with kidney impairment and should be avoided. Seek medical advice before use.
LiverSAFE IF PRESCRIBED
Patients with hepatic impairment can safely use Cipdapla 5mg tablets without requiring any modification to the prescribed dosage.
What if you forget to take Cipdapla 5mg Tablet :
Should you forget a Cipdapla 5mg Tablet dose, take it immediately. However, if your next dose is imminent, omit the missed dose and resume your usual dosing schedule. Never take a double dose.
Facts to Know About Cipdapla 5mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Phenolic Glycoside Derivative |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Action Class | Sodium-glucose cotransporter 2 (SGLT2) inhibitors |
3,018 People bought this recently